Skip to main content

Table 1 Summary of blood purifications

From: Methotrexate-induced acute kidney injury in patients with hematological malignancies: three case reports with literature review

 

Case 1

Case 2

Case 3

HD

 Dialysis treatment time

3 h

3 h

3 h

 Dialyzer

APS®-13 SA

APS®-13SA

APS®-11SA

 Blood flow

150 ml/min

150 ml/min

150 ml/min

 Total number of times

4

2

4

Plasma exchange

 Plasma separator

Plasmaflo®

OP-05 W

Plasmaflo®

OP-05 W

Plasmaflo®

OP-05 W

 Replacement fluid

FFP 2880 ml

5%albumin 2000 ml

FFP 2880 ml

5%albumin 2000 ml

 Total number of times

8

2

FFP 4, albumin 3

Hemoadsorption

 Treatment time

 

3.5 h

 

 Device

 

Hemosorba®CHS350

 

 Total number of times

 

1

 
  1. HD hemodialysis, FFP fresh frozen plasma
  2. APS®-11SA (Asahi Kasei Kuraray Medical Co. Ltd., Tokyo, Japan; Polysulfone, 1.1 m2)
  3. APS®-13SA (Asahi Kasei Kuraray Medical Co. Ltd., Tokyo, Japan; Polysulfone, 1.3 m2)
  4. Plasmaflo® OP-05 W (Asahi Kasei Kuraray Medical Co. Ltd., Tokyo, Japan; Polyethylene, 0.5 m2, Maximum Pore Size 0.3 μm)
  5. Hemosorba® CH-350 (Asahi Kasei Kuraray Medical Co. Ltd.)